Quest Diagnostics Inc. (NYSE: DGX) is a large market cap stock with a market cap of 11781.58. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 14.78, a forward P/E of 15.51 and EPS of 5.72. At a stock price of 83.98 (-0.59%) it has a dividend yield of 1.89%.
EPS growth for the last five years have been 4.10%, more recently this last year it has grown by 28.60%. The next year growth is going to be about 6.70% and more long-term 7.82% after five years. EPS growth quarter over quarter is 68.70%. Sales growth for the past five years have been 0.60% and sales growth quarter over quarter is -1.00%.
For performance, Quest Diagnostics Inc. the past week has seen a gain of -0.90%. For the last month performance for Quest Diagnostics Inc. is 0.04%. While the last quarter is 9.38% and half year, 29.21%. Finally for the year, performance is 28.33%.
The 52-week high for Quest Diagnostics Inc., is at -3.30%, and for the 52-week low it comes to a value of 42.95%. The 20-day simple moving average is 1.61% and 15.12% for the 200-day simple moving average.
Volatility for the week is at 1.19%, and for the month it is 1.10%. Quest Diagnostics Inc., has a target price of 82.5.
In terms of debt, long term debt/equity is 0.85, and for total debt/equity Quest Diagnostics Inc. has 0.85. The gross margin is 38.70%, while operating margin is 20.70%, the profit margin is 11.00%. The current ratio is 1.4 and the quick ratio is 1.3.
Insider ownership is at 0.40%, with instituitional ownership at 96.50%. Quest Diagnostics Inc. has a payout ratio of 27.10%. With the total shares outstanding coming to 139.46. The shares float is 138.48, with the float short at 4.54%, with short ratio coming to 5.36.
In terms of returns, the return on assets see Quest Diagnostics Inc., get 8.20%, with its returns on investment at 12.30%. Return on equity is 17.90%. So will the investors see the target price of 82.5, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.